T32 CA163177/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2012	2
2013	7
2014	11
2015	19
2016	20
2017	16
2018	17
2019	12
2020	18
2021	20
2022	16
2023	13
2024	7

1

Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts.

Rodriguez AB, Peske JD, Woods AN, Leick KM, Mauldin IS, Meneveau MO, Young SJ, Lindsay RS, Melssen MM, Cyranowski S, Parriott G, Conaway MR, Fu YX, Slingluff CL Jr, Engelhard VH. Rodriguez AB, et al. Cell Rep. 2021 Jul 20;36(3):109422. doi: 10.1016/j.celrep.2021.109422. Cell Rep. 2021. PMID: 34289373 Free PMC article.

2

Intron retention and its impact on gene expression and protein diversity: A review and a practical guide.

Grabski DF, Broseus L, Kumari B, Rekosh D, Hammarskjold ML, Ritchie W. Grabski DF, et al. Wiley Interdiscip Rev RNA. 2021 Jan;12(1):e1631. doi: 10.1002/wrna.1631. Epub 2020 Oct 18. Wiley Interdiscip Rev RNA. 2021. PMID: 33073477 Review.

3

Laparoscopic Right Hemicolectomy.

Kane WJ, Friel CM. Kane WJ, et al. Dis Colon Rectum. 2021 May;64(5):e95. doi: 10.1097/DCR.0000000000001989. Dis Colon Rectum. 2021. PMID: 33625055 Free PMC article. No abstract available.

4

Barriers to immune cell infiltration in tumors.

Melssen MM, Sheybani ND, Leick KM, Slingluff CL Jr. Melssen MM, et al. J Immunother Cancer. 2023 Apr;11(4):e006401. doi: 10.1136/jitc-2022-006401. J Immunother Cancer. 2023. PMID: 37072352 Free PMC article. Review.

5

Vaccine Strategy in Melanoma.

Kwak M, Leick KM, Melssen MM, Slingluff CL Jr. Kwak M, et al. Surg Oncol Clin N Am. 2019 Jul;28(3):337-351. doi: 10.1016/j.soc.2019.02.003. Epub 2019 Apr 15. Surg Oncol Clin N Am. 2019. PMID: 31079792 Free PMC article. Review.

6

Recent trends in National Institutes of Health funding for surgery: 2003 to 2013.

Hu Y, Edwards BL, Brooks KD, Newhook TE, Slingluff CL Jr. Hu Y, et al. Am J Surg. 2015 Jun;209(6):1083-9. doi: 10.1016/j.amjsurg.2015.01.015. Epub 2015 Mar 21. Am J Surg. 2015. PMID: 25929766 Free PMC article. Review.

7

Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?

Obeid JM, Kunk PR, Zaydfudim VM, Bullock TN, Slingluff CL Jr, Rahma OE. Obeid JM, et al. Cancer Immunol Immunother. 2018 Feb;67(2):161-174. doi: 10.1007/s00262-017-2082-z. Epub 2017 Oct 20. Cancer Immunol Immunother. 2018. PMID: 29052780 Free PMC article. Review.

8

Vaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future Challenges.

Obeid J, Hu Y, Slingluff CL Jr. Obeid J, et al. Semin Oncol. 2015 Aug;42(4):549-61. doi: 10.1053/j.seminoncol.2015.05.006. Epub 2015 Jun 3. Semin Oncol. 2015. PMID: 26320060 Free PMC article. Review.

9

Immunotherapy as a Complement to Surgical Management of Hepatocellular Carcinoma.

Kim SJ, Cummins KC, Tsung A. Kim SJ, et al. Cancers (Basel). 2024 May 12;16(10):1852. doi: 10.3390/cancers16101852. Cancers (Basel). 2024. PMID: 38791931 Free PMC article. Review.

10

Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer.

Wessel RE, Ageeb N, Obeid JM, Mauldin IS, Goundry KA, Hanson GF, Hossain M, Lehman C, Gentzler RD, Wages NA, Slingluff CL Jr, Bullock TNJ, Dolatshahi S, Brown MG. Wessel RE, et al. J Immunother Cancer. 2024 Sep 18;12(9):e009126. doi: 10.1136/jitc-2024-009126. J Immunother Cancer. 2024. PMID: 39299754 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Results by year